Market Overview

Benzinga's Top #PreMarket Losers

Share:
Related OPTT
Stocks Hitting 52-Week Lows
Morning Market Losers
Related HALO
Halozyme Therapeutics Beats Q4 Views; Outlook Shy Of Consensus
Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2
Halozyme Therapeutics' (HALO) CEO Helen Torley on Q4 2014 Results - Earnings Call Transcript (Seeking Alpha)

Halozyme Therapeutics (NASDAQ: HALO) fell 23.73% to $8.84 in pre-market trading after the company announced the temporary halt of Phase 2 trial enrollment.

Ocean Power Technologies (NASDAQ: OPTT) dipped 17.89% to $3.12 in the pre-market session after the company announced a proposed public offering of common stock.

CarMax (NYSE: KMX) shares dropped 5.38% to $45.00 in pre-market trading after the company reported downbeat Q4 results and lifted its share-buyback authorization by $1 billion.

Cyclacel Pharmaceuticals (NASDAQ: CYCC) dipped 4.85% to $3.53 in pre-market trading after the company priced an underwritten public offering of 2.857 million shares at $3.50 per share.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (CYCC + HALO)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→